Built from public data · pbs.gov.au
Map

The PBAC cosmos

Every drug the PBAC has reviewed, projected onto a single plane. Drugs aren't placed by therapy area or outcome — those labels were never given to the model. Each position is learned from the text of the decisions alone; drugs that read like each other end up near each other. Hover a point; click through to its record.

Pneumococcal Conjugate Vaccine, 20-Valent — Vaccines · Recommended · 2023 Pneumococcal Polysaccharide Conjugate Vaccine, 20-Valent — Vaccines · Recommended · 2022 Abacavir Sulfate With Lamivudine — Infectious disease · Recommended · 2005 Abaloparatide — Endocrinology · Recommended · 2025 Abatacept — Rheumatology · Recommended · 2018 Abemaciclib — Oncology · Recommended · 2023 Abiraterone Acetate And Methylprednisolone — Oncology · Recommended · 2023 Abiraterone Acetate And Prednisolone — Oncology · Recommended · 2025 Abiraterone, Enzalutamide — Oncology · Not recommended · 2021 Abiraterone Acetate, Enzalutamide — Oncology · Recommended · 2021 Abiraterone Acetate — Oncology · Recommended · 2017 Abrocitinib — Dermatology · Recommended · 2024 Acalabrutinib — Haematology · Recommended · 2025 Aciclovir — Ophthalmology · Not recommended · 2021 Aclidinium Bromide — Respiratory · Recommended · 2014 Aclidinium Bromide Plus Eformoterol Fumarate Dihydrate — Respiratory · Recommended · 2015 Adalimumab — Rheumatology · Recommended · 2024 Influenza Vaccine, Adjuvanted — Vaccines · Not recommended · 2019 Adrenaline — Immunology · Deferred · 2018 Adrenaline (Epinephrine) — Immunology · Recommended · 2024 Afatinib — Oncology · Recommended · 2013 Afatinib Dimaleate — Oncology · Not recommended · 2015 Aflibercept — Ophthalmology · Recommended · 2025 Budesonide + Formoterol — Respiratory · Recommended · 2019 Alectinib, Crizotinib, Ceritinib — Oncology · Recommended · 2019 Alectinib — Oncology · Recommended · 2025 Alemtuzumab — Neurology · Not recommended · 2018 Alendronate Sodium — Musculo-skeletal · Recommended · 2011 Alendronic Acid — Musculo-skeletal · Recommended · 2016 Alglucosidase Alfa — Metabolic · Not recommended · 2013 Alirocumab — Cardiovascular · Recommended · 2023 Alogliptin With Metformin — Endocrinology · Recommended · 2013 Alogliptin — Endocrinology · Recommended · 2013 Amifampridine — Neurology · Recommended · 2022 Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine And Isoleucine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals (Msud, Tyr, Hcu Coolers) — Metabolic · Recommended · 2018 Amino Acid Formula With Vitamins And Minerals Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals (Three Formulations: Without Phenylalanine; Without Phenylalanine And Tyrosine; Without Valine, Leucine And Isoleucine) — Metabolic · Recommended · 2015 Amino Acid Formula With Fat, Carbohydrate, Vitamins, Minerals, Trace Elements And Medium Chain Triglycerides — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals Without Lysine And Low In Tryptophan — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals Without Methionine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals Without Methionine And Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula With Vitamins And Minerals (Multiple Formulations) — Metabolic · Recommended · 2021 Amino Acid Formula With Vitamins And Minerals Without Methionine, Threonine And Valine And Low In Isoleucine — Metabolic · Recommended · 2024 Amino Acid Formula With Fat, Carbohydrate, Without Valine, Leucine And Isoleucine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine, Isoleucine, Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals, Low Phenylalanine And Supplemented With Docosahexaenoic Acid And Arachidonic Acid — Metabolic · Recommended · 2019 Amino Acid Formula With Fat, Carbohydrate, Vitamins And Minerals Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Carbohydrate Without Phenylalanine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals, Without Phenylalanine — Metabolic · Recommended · 2017 Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids, Without Phenylalanine — Metabolic · Recommended · 2018 Amino Acid Formula With Carbohydrate, Vitamins, Minerals And Trace Elements Without Phenylalanine, Supplemented With Docosahexaenoic Acid — Metabolic · Not recommended · 2020 Amino Acid Formula With Fat, Carbohydrate Without Phenylalanine And Tyrosine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals Without Phenylalanine And Tyrosine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals, Without Phenylalanine And Tyrosine, Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula (Multiple Formulations For Pku, Tyrosinaemia, Ga1, Mma/Pa, Hcu, Msud) — Metabolic · Recommended · 2020 Amino Acid Formula Without Phenylalanine — Metabolic · Recommended · 2016 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids, Medium Chain Triglycerides, 2'-Fucosyllactose And Lacto-N-Neotetraose — Metabolic · Recommended · 2022 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2023 Amino Acid Synthetic Formula — Metabolic · Recommended · 2015 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids; Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2020 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids And Medium Chain Triglycerides — Gastroenterology · Recommended · 2015 Amino Acids – Synthetic, Formula — Metabolic · Recommended · 2018 Amivantamab And Lazertinib — Oncology · Recommended · 2025 Amivantamab — Oncology · Recommended · 2024 Anakinra — Rare disease · Not recommended · 2017 Anastrozole — Oncology · Recommended · 2005 Anifrolumab — Rheumatology · Recommended · 2024 Betaxolol, Bimatoprost, Bimatoprost + Timolol, Brimonidine, Brimonidine + Timolol, Brinzolamide, Brinzolamide + Timolol, Dorzolamide, Dorzolamide + Timolol, Latanoprost, Latanoprost + Timolol, Pilocarpine, Timolol, Travoprost, Timolol + Travoprost — Ophthalmology · Recommended · 2015 Amoxicillin, Amoxicillin With Clavulanic Acid, Cefalexin, Doxycycline, Roxithromycin — Infectious disease · Recommended · 2019 Quetiapine — Mental health · Recommended · 2018 Antiretroviral Therapy (Art) — Combination Regimens — Infectious disease · Not recommended · 2013 Apalutamide — Oncology · Recommended · 2024 Apixaban — Cardiovascular · Recommended · 2015 Apomorphine — Neurology · Recommended · 2025 Apomorphine Hydrochloride — Neurology · Recommended · 2018 Apomorphine Hydrochloride Hemihydrate — Neurology · Recommended · 2018 Apremilast — Dermatology · Recommended · 2023 Aprepitant — Oncology · Recommended · 2019 Arginine — Metabolic · Not recommended · 2017 Aripiprazole — Mental health · Recommended · 2025 Modafinil; Armodafinil — Neurology · Not recommended · 2020 Armodafinil — Neurology · Recommended · 2016 Arsenic Trioxide — Haematology · Not recommended · 2015 Asciminib — Haematology · Recommended · 2022 Asfotase Alfa Rch — Rare disease · Not recommended · 2018 Asunaprevir — Hepatology · Recommended · 2015 Atazanavir/Cobicistat — Infectious disease · Recommended · 2015 Atezolizumab — Oncology · Recommended · 2024 Atogepant — Neurology · Recommended · 2023 Ezetimibe + Atorvastatin — Cardiovascular · Recommended · 2014 Auranofin — Rheumatology · Recommended · 2017 Avacopan — Immunology · Not recommended · 2024 Avalglucosidase Alfa — Rare disease · Recommended · 2021 Avatrombopag — Haematology · Recommended · 2022 Avelumab — Oncology · Recommended · 2022 Axitinib — Oncology · Recommended · 2014 Azacitidine — Haematology · Recommended · 2022 Baclofen — Neurology · Recommended · 2017 Balsalazide — Gastroenterology · Recommended · 2017 Baricitinib — Dermatology · Recommended · 2021 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate — Respiratory · Recommended · 2024 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate And Glycopyrronium — Respiratory · Recommended · 2022 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate And Glycopyrronium Bromide — Respiratory · Recommended · 2020 Beclometasone With Formoterol — Respiratory · Recommended · 2022 Belantamab Mafodotin — Oncology · Recommended · 2025 Belimumab — Rheumatology · Recommended · 2020 Belzutifan — Oncology · Recommended · 2024 Bendamustine — Haematology · Recommended · 2015 Benralizumab — Respiratory · Recommended · 2020 Benzathine Benzylpenicillin — Infectious disease · Recommended · 2019 Benztropine Mesylate — Neurology · Recommended · 2015 Betaine — Metabolic · Recommended · 2014 Bevacizumab — Oncology · Recommended · 2024 Bezlotoxumab — Infectious disease · Not recommended · 2020 Bimatoprost — Ophthalmology · Recommended · 2020 Bimekizumab — Dermatology · Recommended · 2025 Biologics (Etanercept, Infliximab, Adalimumab, Ustekinumab, Secukinumab, Ixekizumab, Guselkumab, Tildrakizumab) — Dermatology · Not recommended · 2020 Blinatumomab — Haematology · Recommended · 2024 Bortezomib — Oncology · Recommended · 2022 Botulinum Toxin Type A — Neurology · Recommended · 2019 Botulinum Toxin Type A Purified Neurotoxin Complex — Neurology · Recommended · 2019 Brentuximab Vedotin — Oncology · Recommended · 2025 Brexpiprazole — Mental health · Recommended · 2025 Brigatinib — Oncology · Not recommended · 2019 Brinzolamide/Brimonidine Tartrate — Ophthalmology · Recommended · 2015 Brivaracetam — Neurology · Recommended · 2019 Pembrolizumab — Oncology · Not recommended · 2025 Brolucizumab — Ophthalmology · Recommended · 2021 Budesonide / Glycopyrronium / Formoterol — Respiratory · Recommended · 2021 Budesonide With Formoterol — Respiratory · Recommended · 2023 Budesonide — Gastroenterology · Recommended · 2024 Budesonide With Eformoterol Fumarate Dihydrate — Respiratory · Recommended · 2017 Budesonide With Glycopyrronium And Formoterol — Respiratory · Recommended · 2022 Bulevirtide — Hepatology · Not recommended · 2025 Buprenorphine; Oxycodone + Naloxone — Pain · Deferred · 2015 Buprenorphine — Pain · Recommended · 2021 Buprenorphine With Naloxone — Pain · Not recommended · 2020 Buprenorphine/Naloxone — Pain · Recommended · 2019 Buprenorphine + Naloxone — Pain · Recommended · 2014 Burosumab — Endocrinology · Recommended · 2022 Cabazitaxel — Oncology · Recommended · 2022 Cabotegravir — Infectious disease · Recommended · 2023 Cabotegravir And Rilpivirine — Infectious disease · Recommended · 2021 Cabozantinib — Oncology · Not recommended · 2025 Calcipotriol + Betamethasone Dipropionate — Dermatology · Recommended · 2015 Calcipotriol With Betamethasone Dipropionate — Dermatology · Recommended · 2025 Calcium Carbonate — Endocrinology · Recommended · 2019 Canagliflozin — Endocrinology · Recommended · 2013 Canakinumab — Rare disease · Recommended · 2017 Cannabidiol — Neurology · Not recommended · 2025 Caplacizumab — Haematology · Recommended · 2020 Carbohydrate, Fat, Vitamins, Minerals And Trace Elements — Metabolic · Recommended · 2020 Carbohydrate Formula With Minerals — Metabolic · Not recommended · 2016 Carfilzomib — Oncology · Recommended · 2022 Carglumic Acid — Metabolic · Not recommended · 2015 Cariprazine — Mental health · Recommended · 2020 Carmellose Sodium; Hypromellose — Ophthalmology · Recommended · 2019 Carmellose Sodium With Glycerol And Hyaluronic Acid — Ophthalmology · Recommended · 2023 Cationic Ophthalmic Emulsion, Preservative Free — Ophthalmology · Recommended · 2020 Cefuroxime Axetil — Infectious disease · Recommended · 2015 Cemiplimab — Oncology · Recommended · 2023 Pneumococcal Conjugate Vaccine 13-Valent (13vpcv) And Pneumococcal Polysaccharide Vaccine 23-Valent (23vppv) — Vaccines · Recommended · 2019 Ceritinib — Oncology · Recommended · 2016 Cerliponase Alfa — Rare disease · Recommended · 2018 Certolizumab Pegol — Dermatology · Recommended · 2019 Cetrorelix — Women's health · Recommended · 2025 Cetuximab — Oncology · Recommended · 2024 Chlormethine Hydrochloride — Dermatology · Recommended · 2023 Chorionic Gonadotrophin — Women's health · Recommended · 2017 Ciclosporin — Ophthalmology · Recommended · 2022 Cinacalcet — Endocrinology · Recommended · 2019 Cipaglucosidase Alfa With Miglustat — Metabolic · Not recommended · 2025 Citrulline — Metabolic · Recommended · 2015 Cladribine — Neurology · Not recommended · 2023 Clobetasol Propionate — Dermatology · Not recommended · 2024 Clostridium Botulinum Type A Toxin-Haemagglutinin Complex — Neurology · Recommended · 2020 Clostridium Botulinum Type A Toxin – Haemagglutinin Complex — Neurology · Recommended · 2019 Clozapine — Mental health · Recommended · 2018 Coal Tar Prepared — Dermatology · Recommended · 2014 Cobicistat + Elvitegravir + Emtricitabine + Tenofovir — Infectious disease · Recommended · 2013 Cobicistat — Infectious disease · Not recommended · 2013 Vemurafenib + Cobimetinib — Oncology · Recommended · 2016 Collagenase Clostridium Histolyticum — Other · Not recommended · 2014 Corifollitropin Alfa — Women's health · Recommended · 2013 Crisaborole — Dermatology · Deferred · 2020 Crizotinib — Oncology · Recommended · 2018 Dabigatran Etexilate — Cardiovascular · Recommended · 2012 Dabrafenib And Trametinib — Oncology · Recommended · 2025 Dabrafenib + Trametinib — Oncology · Recommended · 2019 Dabrafenib — Oncology · Recommended · 2013 Daclatasvir — Hepatology · Not recommended · 2015 Daclizumab — Neurology · Recommended · 2016 Dactylis Glomerata With Poa Pratensis, Lolium Perenne, Anthoxanthum Odoratum And Phleum Pratense — Immunology · Not recommended · 2016 Dapagliflozin And Metformin Extended Release — Endocrinology · Recommended · 2015 Dapagliflozin — Endocrinology · Recommended · 2025 Dapagliflozin With Metformin — Endocrinology · Deferred · 2017 Dapagliflozin/Saxagliptin — Diabetes · Deferred · 2017 Dapagliflozin With Sitagliptin — Endocrinology · Recommended · 2024 Dapsone — Dermatology · Recommended · 2025 Daratumumab — Haematology · Recommended · 2025 Darbepoetin Alfa — Oncology · Recommended · 2019 Darolutamide — Oncology · Recommended · 2022 Darunavir With Cobicistat With Emtricitabine And Tenofovir Alafenamide — Infectious disease · Recommended · 2019 Darunavir + Cobicistat — Infectious disease · Recommended · 2016 Darunavir/Cobicistat — Infectious disease · Recommended · 2015 Dasatinib — Haematology · Recommended · 2019 Daunorubicin With Cytarabine (Liposomal) — Haematology · Recommended · 2023 Daunorubicin With Cytarabine — Haematology · Recommended · 2023 Liposomal Daunorubicin And Cytarabine — Haematology · Recommended · 2024 Decitabine With Cedazuridine — Haematology · Recommended · 2021 Decitabine + Cedazuridine — Haematology · Deferred · 2021 Deferasirox — Haematology · Recommended · 2020 Deferiprone — Rare disease · Recommended · 2017 Degarelix — Oncology · Recommended · 2017 Delgocitinib — Dermatology · Recommended · 2025 Denosumab — Endocrinology · Recommended · 2025 Desmopressin Acetate — Endocrinology · Recommended · 2025 Deucravacitinib — Dermatology · Deferred · 2023 Deutetrabenazine — Neurology · Not recommended · 2021 Dexamethasone — Ophthalmology · Not recommended · 2018 Dienogest — Women's health · Recommended · 2024 Difelikefalin — Nephrology · Recommended · 2023 Dimethyl Fumarate — Neurology · Recommended · 2019 Diroximel Fumarate — Neurology · Recommended · 2022 Docetaxel — Oncology · Recommended · 2017 Dolutegravir + Abacavir + Lamivudine — Infectious disease · Recommended · 2014 Dolutegravir — Infectious disease · Recommended · 2013 Dolutegravir/Rilpivirine — Infectious disease · Recommended · 2018 Dolutegravir With Lamivudine — Infectious disease · Recommended · 2020 Donanemab — Neurology · Recommended · 2025 Dorzolamide With Timolol — Ophthalmology · Recommended · 2022 Dostarlimab — Oncology · Recommended · 2025 Drospirenone — Women's health · Recommended · 2024 Drospirenone With Ethinylestradiol — Women's health · Not recommended · 2024 Direct-Acting Antiviral (Daa) Regimens — Hepatology · Not recommended · 2019 Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis And Haemophilus Influenzae Type B Conjugate Vaccine — Vaccines · Recommended · 2022 Dtpa-Hepb-Ipv-Hib Vaccine — Vaccines · Recommended · 2015 Diphtheria + Tetanus + Acellular Pertussis Vaccine — Vaccines · Not recommended · 2014 Diphtheria, Tetanus, Acellular Pertussis Vaccine (Dtpa) — Vaccines · Not recommended · 2016 Diphtheria And Tetanus Toxoids Combined With Pertussis Vaccine-Acellular — Vaccines · Recommended · 2017 Dulaglutide — Endocrinology · Recommended · 2022 Dupilumab — Dermatology · Recommended · 2025 Durvalumab, Olaparib — Oncology · Recommended · 2024 Durvalumab — Oncology · Recommended · 2025 Durvalumab And Tremelimumab — Oncology · Recommended · 2025 Eculizumab — Neurology · Recommended · 2021 Edaravone — Neurology · Recommended · 2024 Efalizumab — Dermatology · Recommended · 2008 Efgartigimod Alfa — Neurology · Recommended · 2025 Eflornithine — Oncology · Recommended · 2025 Elacestrant — Oncology · Recommended · 2025 Elafibranor — Hepatology · Recommended · 2025 Elexacaftor/Tezacaftor/Ivacaftor — Rare disease · Recommended · 2022 Elexacaftor With Tezacaftor And With Ivacaftor, And Ivacaftor — Rare disease · Recommended · 2025 Eliglustat — Metabolic · Recommended · 2015 Elosulfase Alfa — Metabolic · Not recommended · 2016 Elotuzumab — Oncology · Recommended · 2021 Elranatamab — Haematology · Other · 2025 Eltrombopag — Haematology · Recommended · 2023 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide — Infectious disease · Recommended · 2015 Elvitegravir — Infectious disease · Not recommended · 2013 Empagliflozin — Endocrinology · Deferred · 2025 Empagliflozin/Metformin — Endocrinology · Recommended · 2015 Empagliflozin, Empagliflozin With Metformin, Linagliptin, Linagliptin With Metformin — Endocrinology · Recommended · 2017 Empagliflozin With Linagliptin — Endocrinology · Recommended · 2017 Tenofovir Alafenamide / Emtricitabine / Rilpivirine — Infectious disease · Recommended · 2016 Encorafenib — Oncology · Recommended · 2025 Encorafenib; Binimetinib — Oncology · Recommended · 2018 Enfortumab Vedotin — Oncology · Recommended · 2024 Enoxaparin Sodium — Cardiovascular · Recommended · 2020 Enoxaparin — Cardiovascular · Recommended · 2025 Entrectinib — Oncology · Recommended · 2020 Enzalutamide — Oncology · Recommended · 2024 Epcoritamab — Haematology · Recommended · 2024 Eplerenone — Cardiovascular · Not recommended · 2025 Epoetin Lambda — Haematology · Recommended · 2017 Epoprostenol — Respiratory · Recommended · 2016 Eptinezumab — Neurology · Recommended · 2022 Erenumab — Neurology · Recommended · 2024 Eribulin Mesilate — Oncology · Recommended · 2013 Eribulin — Oncology · Recommended · 2016 Erlotinib — Oncology · Recommended · 2013 Ertugliflozin — Endocrinology · Recommended · 2018 Ertugliflozin With Sitagliptin — Endocrinology · Recommended · 2018 Escitalopram — Mental health · Recommended · 2014 Esketamine — Mental health · Recommended · 2024 Eslicarbazepine Acetate — Neurology · Recommended · 2021 Essential Amino Acids Formula With Vitamins And Minerals — Metabolic · Recommended · 2021 Estetrol With Drospirenone — Women's health · Not recommended · 2025 Estradiol; Progesterone; Estradiol And Progesterone Combination — Women's health · Recommended · 2024 Estradiol — Endocrinology · Recommended · 2024 Estradiol With Progesterone — Women's health · Recommended · 2025 Etanercept — Rheumatology · Recommended · 2025 Etonogestrel With Ethinylestradiol — Women's health · Deferred · 2025 Etrasimod — Gastroenterology · Recommended · 2024 Everolimus — Neurology · Recommended · 2017 Evolocumab — Cardiovascular · Recommended · 2024 Exenatide — Endocrinology · Recommended · 2019 Ezetimibe And Atorvastatin — Cardiovascular · Recommended · 2013 Ezetimibe + Rosuvastatin — Cardiovascular · Recommended · 2014 Ezetimibe And Rosuvastatin — Cardiovascular · Recommended · 2013 Ezetimibe With Simvastatin — Cardiovascular · Not recommended · 2012 Ezetimibe + Simvastatin — Cardiovascular · Not recommended · 2014 Fampridine — Neurology · Not recommended · 2014 Faricimab — Ophthalmology · Recommended · 2025 Febuxostat — Rheumatology · Not recommended · 2017 Fedratinib — Haematology · Recommended · 2025 Fenfluramine — Neurology · Recommended · 2024 Fentanyl Citrate — Pain · Recommended · 2017 Fentanyl — Pain · Not recommended · 2014 Ferric Carboxymaltose — Other · Recommended · 2018 Ferric Derisomaltose — Metabolic · Deferred · 2019 Fezolinetant — Women's health · Not recommended · 2025 Filgrastim — Haematology · Recommended · 2018 Finerenone — Endocrinology · Recommended · 2023 Fingolimod, Ofatumumab, Siponimod — Neurology · Recommended · 2024 Fingolimod — Neurology · Recommended · 2019 Flucloxacillin — Infectious disease · Recommended · 2015 Fluocinolone Acetonide — Ophthalmology · Recommended · 2020 Fluticasone Furoate — Respiratory · Recommended · 2019 Fluticasone Furoate / Umeclidinium / Vilanterol — Respiratory · Recommended · 2021 Fluticasone Propionate With Eformoterol Fumarate — Respiratory · Recommended · 2013 Fluticasone Propionate With Salmeterol — Respiratory · Recommended · 2023 Fluticasone Propionate With Formoterol Fumarate Dihydrate — Respiratory · Not recommended · 2018 Fluticasone Furoate + Vilanterol — Respiratory · Recommended · 2014 Fluticasone Propionate With Salmeterol Xinafoate — Respiratory · Not recommended · 2016 Fluticasone Furoate/Vilanterol — Respiratory · Not recommended · 2014 Fluticasone Furoate / Vilanterol Trifenatate — Respiratory · Recommended · 2014 Follitropin Alfa — Women's health · Not recommended · 2021 Follitropin Alfa With Lutropin Alfa — Women's health · Recommended · 2024 Follitropin Alfa + Lutropin Alfa; Lutropin Alfa — Women's health · Recommended · 2016 Follitropin Alfa And Lutropin Alfa — Women's health · Recommended · 2015 Follitropin Delta — Women's health · Recommended · 2017 Fosaprepitant — Oncology · Recommended · 2016 Foslevodopa With Foscarbidopa — Neurology · Recommended · 2024 Fosnetupitant/Palonosetron — Gastroenterology · Recommended · 2023 Fosnetupitant With Palonosetron — Oncology · Recommended · 2020 Fremanezumab — Neurology · Recommended · 2022 Fruquintinib — Oncology · Recommended · 2024 Fulvestrant — Oncology · Recommended · 2020 Futibatinib — Oncology · Not recommended · 2025 Galcanezumab — Neurology · Recommended · 2022 Garadacimab — Rare disease · Recommended · 2024 Gefitinib — Oncology · Not recommended · 2013 Gemcitabine — Oncology · Recommended · 2025 Gemtuzumab Ozogamicin — Haematology · Recommended · 2021 Gilteritinib — Haematology · Recommended · 2022 Givosiran — Hepatology · Recommended · 2025 Glatiramer Acetate — Neurology · Recommended · 2022 Glecaprevir With Pibrentasvir — Hepatology · Deferred · 2020 Glofitamab — Haematology · Recommended · 2025 Glucose Indicator Blood Strip — Endocrinology · Recommended · 2016 Glycine With Carbohydrate — Metabolic · Recommended · 2014 Glycomacropeptide And Essential Amino Acids With Vitamins And Minerals — Metabolic · Recommended · 2024 Glycomacropeptide Formula With Docosahexaenoic Acid And Low Phenylalanine — Metabolic · Recommended · 2019 Glycomacropeptide And Essential Amino Acids — Metabolic · Recommended · 2016 Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low In Phenylalanine — Metabolic · Recommended · 2022 Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low Phenylalanine — Metabolic · Recommended · 2017 Glycomacropeptide Formula With Amino Acids And Low Phenylalanine — Metabolic · Recommended · 2022 Glycomacropeptide Formula With Amino Acids, Vitamins, Minerals, Trace Elements, Carbohydrate, Fat And Low Phenylalanine — Metabolic · Recommended · 2022 Glycomacropeptide Formula With Docosahexaenoic Acid With Low Phenylalanine — Metabolic · Recommended · 2018 Glycopyrronium Bromide — Respiratory · Not recommended · 2015 Glycopyrronium — Dermatology · Recommended · 2025 Golimumab — Rheumatology · Recommended · 2018 Golimumab; Infliximab; Ustekinumab — Rheumatology · Deferred · 2014 Human Menopausal Gonadotrophin — Women's health · Recommended · 2022 Gonadotrophin-Menopausal Human (Highly Purified Human Menopausal Gonadotrophin, Hp-Hmg) — Women's health · Not recommended · 2016 Goserelin — Women's health · Recommended · 2017 Grazoprevir / Elbasvir — Hepatology · Recommended · 2016 Grazoprevir With Elbasvir — Hepatology · Deferred · 2018 Guanfacine — Neurology · Recommended · 2018 Guselkumab — Gastroenterology · Recommended · 2025 Hepatitis B Surface Antigen Recombinant Vaccine — Vaccines · Recommended · 2018 High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein And Carbohydrate — Metabolic · Recommended · 2023 Inactivated Trivalent Influenza Vaccine (Split Virion), High Dose — Vaccines · Not recommended · 2019 High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein Carbohydrate — Metabolic · Recommended · 2016 Insect Allergen Extract - Honey Bee Venom, Yellow Jacket Venom, Paper Wasp Venom — Immunology · Recommended · 2016 House Dust Mite Allergen Extract — Immunology · Recommended · 2016 Human Papillomavirus 9-Valent Vaccine — Vaccines · Recommended · 2022 Human Papillomavirus (Hpv) Types 16/18 Vaccine — Vaccines · Recommended · 2015 Hyaluronic Acid With Polyethylene Glycol 400 With Propylene Glycol With Hydroxypropyl Guar — Ophthalmology · Recommended · 2023 Hydrocortisone — Endocrinology · Recommended · 2021 Hydromorphone Hydrochloride — Pain · Recommended · 2018 Hypromellose — Ophthalmology · Recommended · 2021 Ibrutinib — Haematology · Recommended · 2024 Icatibant — Rare disease · Recommended · 2017 Icosapent Ethyl — Cardiovascular · Recommended · 2024 Idelalisib — Haematology · Recommended · 2016 Imatinib — Haematology · Recommended · 2021 Inactivated Trivalent Influenza Vaccine (Surface Antigen), Adjuvanted — Vaccines · Recommended · 2018 Inactivated Quadrivalent Influenza Vaccine (Split Virion) — Vaccines · Recommended · 2020 Inactivated Trivalent Influenza Vaccine (Split Virion) — Vaccines · Recommended · 2018 Inclisiran — Cardiovascular · Recommended · 2024 Incobotulinumtoxin A — Neurology · Recommended · 2024 Incobotulinumtoxina — Neurology · Recommended · 2025 Mometasone Furoate With Indacaterol And Glycopyrronium — Respiratory · Recommended · 2020 Indacaterol With Glycopyrronium — Respiratory · Recommended · 2014 Indacaterol + Glycopyrronium — Respiratory · Recommended · 2014 Mometasone Furoate With Indacaterol — Respiratory · Recommended · 2020 Infliximab — Rheumatology · Recommended · 2025 Influenza Vaccine, Adjuvanted Quadrivalent And Adjuvanted Trivalent — Vaccines · Not recommended · 2019 Quadrivalent Influenza Vaccine — Vaccines · Recommended · 2019 Quadrivalent Recombinant Influenza Vaccine — Vaccines · Recommended · 2024 Cell-Cultured Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) — Vaccines · Recommended · 2024 Inactivated Quadrivalent Influenza Vaccine — Vaccines · Recommended · 2016 Ingenol Mebutate — Dermatology · Not recommended · 2014 Inotuzumab Ozogamicin — Haematology · Recommended · 2019 Insect Allergen Extract – Honey Bee Venom; Insect Allergen Extract – Paper Wasp Venom; Insect Allergen Extract – Yellow Jacket Venom — Immunology · Recommended · 2018 Insulin Degludec — Endocrinology · Recommended · 2025 Insulin Aspart — Endocrinology · Recommended · 2021 Insulin Degludec With Insulin Aspart — Endocrinology · Recommended · 2018 Insulin Detemir — Endocrinology · Recommended · 2007 Insulin Glargine — Endocrinology · Recommended · 2018 Insulin Glargine With Lixisenatide — Endocrinology · Recommended · 2019 Insulin Lispro — Endocrinology · Recommended · 2017 Ipilimumab — Oncology · Recommended · 2016 Iptacopan — Rare disease · Recommended · 2025 Irinotecan (Nanoliposomal) — Oncology · Not recommended · 2024 Iron (As Sucrose) — Haematology · Recommended · 2014 Isotretinoin — Dermatology · Recommended · 2019 Itraconazole — Infectious disease · Recommended · 2015 Ivabradine — Cardiovascular · Recommended · 2015 Ivacaftor — Rare disease · Recommended · 2025 Ivermectin — Dermatology · Recommended · 2014 Ivosidenib — Oncology · Recommended · 2024 Ixazomib — Haematology · Recommended · 2022 Ixekizumab — Rheumatology · Recommended · 2023 Lacosamide — Neurology · Recommended · 2021 Lanadelumab — Immunology · Recommended · 2024 Lanreotide Acetate — Endocrinology · Recommended · 2017 Lanreotide — Endocrinology · Recommended · 2024 Larotrectinib — Oncology · Not recommended · 2024 Latanoprost With Timolol Maleate — Ophthalmology · Recommended · 2005 Lebrikizumab — Dermatology · Recommended · 2024 Ledipasvir/Sofosbuvir — Hepatology · Recommended · 2015 Lenacapavir — Infectious disease · Recommended · 2023 Lenalidomide — Haematology · Recommended · 2023 Leniolisib — Rare disease · Recommended · 2025 Lenvatinib — Hepatology · Recommended · 2018 Letermovir — Infectious disease · Recommended · 2019 Leuprorelin — Endocrinology · Recommended · 2024 Leuprorelin Acetate — Endocrinology · Not recommended · 2022 Leuprorelin And Bicalutamide — Oncology · Recommended · 2016 Levodopa With Carbidopa Monohydrate — Neurology · Recommended · 2019 Levodopa With Carbidopa And Entacapone — Neurology · Not recommended · 2024 Levodopa With Carbidopa — Neurology · Recommended · 2016 Levonorgestrel — Women's health · Recommended · 2019 Lignocaine — Pain · Recommended · 2015 Linagliptin With Metformin Hydrochloride — Endocrinology · Deferred · 2013 Linagliptin — Endocrinology · Recommended · 2016 Linezolid — Infectious disease · Recommended · 2013 Linzagolix — Women's health · Not recommended · 2024 Lipegfilgrastim — Oncology · Not recommended · 2016 Liraglutide — Endocrinology · Not recommended · 2018 Lisdexamfetamine — Neurology · Recommended · 2020 Lisdexamfetamine Dimesilate — Mental health · Recommended · 2014 Lixisenatide — Endocrinology · Recommended · 2014 Lorlatinib — Oncology · Deferred · 2021 Lumacaftor With Ivacaftor — Rare disease · Recommended · 2023 Lumacaftor And Ivacaftor — Rare disease · Not recommended · 2021 Lumacaftor/Ivacaftor — Rare disease · Not recommended · 2019 Lumasiran — Rare disease · Recommended · 2025 Lurasidone Hydrochloride — Mental health · Not recommended · 2014 Lurasidone — Mental health · Not recommended · 2015 Lurbinectedin — Oncology · Recommended · 2025 Lutropin Alfa — Women's health · Recommended · 2015 Macitentan — Cardiovascular · Recommended · 2014 Macitentan With Tadalafil — Respiratory · Recommended · 2024 Mannitol — Respiratory · Recommended · 2017 Maribavir — Infectious disease · Recommended · 2024 Mavacamten — Cardiovascular · Recommended · 2023 Mecasermin — Endocrinology · Deferred · 2022 Triglycerides, Long Chain; Triglycerides, Medium Chain — Metabolic · Recommended · 2017 Triglycerides, Medium Chain; Triglycerides, Long Chain — Metabolic · Not recommended · 2017 Medroxyprogesterone Acetate — Women's health · Recommended · 2023 Melatonin — Neurology · Recommended · 2021 Melatonin Prolonged Release — Neurology · Not recommended · 2021 Meningococcal Polysaccharide Conjugate Vaccine Serogroups A, C, W-135 And Y — Vaccines · Recommended · 2018 Meningococcal (Groups A, C, W-135 And Y) Oligosaccharide Crm197 Conjugate Vaccine — Vaccines · Recommended · 2023 Meningococcal Group B Vaccine (4cmenb) — Vaccines · Not recommended · 2013 Meningococcal Polysaccharide Serogroups A, C, W-135 And Y Conjugate Vaccine — Vaccines · Recommended · 2020 Mepolizumab — Respiratory · Recommended · 2024 Mercaptopurine — Haematology · Recommended · 2014 Mesalazine — Gastroenterology · Recommended · 2020 Metformin And Saxagliptin — Endocrinology · Recommended · 2013 Metformin And Sitagliptin — Endocrinology · Recommended · 2013 Methadone — Pain · Recommended · 2025 Methotrexate — Rheumatology · Recommended · 2018 Methotrexate (As Sodium) — Rheumatology · Recommended · 2024 Methoxsalen — Haematology · Recommended · 2021 Methylphenidate Hydrochloride Extended Release — Neurology · Not recommended · 2007 Methylphenidate Hydrochloride — Neurology · Recommended · 2022 Midazolam — Neurology · Recommended · 2023 Midazolam Maleate — Neurology · Recommended · 2022 Midostaurin — Haematology · Recommended · 2025 Mifepristone And Misoprostol — Women's health · Recommended · 2023 Migalastat — Rare disease · Recommended · 2024 Milk Powder - Lactose Intolerance Formula — Other · Recommended · 2017 Milk Powder Synthetic Low Calcium — Metabolic · Recommended · 2020 Milk Powder Synthetic, Low Calcium Oral Powder — Metabolic · Recommended · 2024 Milk Protein And Fat Formula With Vitamins And Minerals, Carbohydrate Free — Metabolic · Recommended · 2020 Mirikizumab — Gastroenterology · Recommended · 2023 Mirvetuximab Soravtansine — Oncology · Other · 2025 Mobocertinib — Oncology · Recommended · 2023 Modafinil, Armodafinil — Neurology · Recommended · 2022 Capecitabine, Megestrol, Toremifene, Vinorelbine — Oncology · Recommended · 2014 Mogamulizumab — Oncology · Not recommended · 2025 Molnupiravir — Infectious disease · Recommended · 2023 Momelotinib — Haematology · Recommended · 2024 Morphine Sulfate Pentahydrate — Pain · Recommended · 2024 Morphine Hydrochloride — Pain · Recommended · 2016 Meningococcal Group B Vaccine (Recombinant, Adsorbed) — Vaccines · Not recommended · 2015 Meningococcal Group B Vaccine, Multicomponent (4cmenb) — Vaccines · Recommended · 2019 Mupirocin — Infectious disease · Recommended · 2019 Nabiximols — Neurology · Recommended · 2020 Nadroparin Calcium — Cardiovascular · Recommended · 2016 Nalmefene — Mental health · Not recommended · 2015 Naloxone — Pain · Recommended · 2019 Nandrolone Decanoate — Endocrinology · Not recommended · 2018 Naproxen And Esomeprazole — Rheumatology · Not recommended · 2013 Natalizumab — Neurology · Recommended · 2025 Nemolizumab — Dermatology · Recommended · 2025 Neratinib — Oncology · Not recommended · 2019 Netupitant And Palonosetron — Oncology · Recommended · 2015 Netupitant/Palonosetron — Oncology · Recommended · 2015 Netupitant With Palonosetron — Oncology · Recommended · 2023 Nicotine — Addiction medicine · Recommended · 2018 Nintedanib — Respiratory · Not recommended · 2024 Niraparib — Oncology · Recommended · 2023 Nirmatrelvir And Ritonavir — Infectious disease · Recommended · 2023 Nirsevimab — Vaccines · Not recommended · 2025 Nitisinone — Metabolic · Not recommended · 2015 Nivolumab And Ipilimumab — Oncology · Not recommended · 2024 Nivolumab + Ipilimumab — Oncology · Recommended · 2022 Nivolumab — Oncology · Recommended · 2024 Nivolumab Plus Ipilimumab — Oncology · Recommended · 2020 Nivolumab; Ipilimumab — Oncology · Recommended · 2025 Nusinersen — Neurology · Recommended · 2023 Obeticholic Acid — Hepatology · Recommended · 2021 Obinutuzumab — Haematology · Recommended · 2018 Ocrelizumab — Neurology · Recommended · 2025 Ocriplasmin — Ophthalmology · Recommended · 2019 Octreotide — Oncology · Recommended · 2019 Ocular Lubricants (Multiple Active Ingredients) — Ophthalmology · Recommended · 2014 Odevixibat — Hepatology · Recommended · 2025 Ofatumumab — Neurology · Not recommended · 2024 Olaparib — Oncology · Recommended · 2024 Olipudase Alfa — Rare disease · Recommended · 2023 Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide — Cardiovascular · Recommended · 2013 Olodaterol — Respiratory · Not recommended · 2014 Omalizumab — Immunology · Recommended · 2025 Omaveloxolone — Rare disease · Not recommended · 2025 Onasemnogene Abeparvovec — Rare disease · Not recommended · 2023 Ondansetron — Oncology · Recommended · 2020 Buprenorphine, Buprenorphine With Naloxone, Methadone — Pain · Recommended · 2023 Opicapone — Neurology · Recommended · 2021 Osilodrostat — Endocrinology · Recommended · 2024 Osimertinib — Oncology · Recommended · 2025 Oxybutynin — Urology · Recommended · 2023 Oxycodone Hydrochloride + Naloxone Hydrochloride — Pain · Recommended · 2015 Oxycodone — Pain · Not recommended · 2019 Oxycodone With Naloxone — Pain · Recommended · 2016 Oxycodone Hydrochloride — Pain · Not recommended · 2015 Ozanimod — Gastroenterology · Recommended · 2022 Paclitaxel, Nanoparticle Albumin-Bound — Oncology · Recommended · 2019 Nab-Paclitaxel — Oncology · Not recommended · 2015 Paclitaxel-Nanoparticle Albumin Bound — Oncology · Recommended · 2014 Palbociclib — Oncology · Recommended · 2022 Paliperidone — Mental health · Recommended · 2025 Paliperidone Palmitate — Mental health · Recommended · 2022 Palopegteriparatide — Endocrinology · Recommended · 2025 Palovarotene — Rare disease · Recommended · 2024 Pancreatic Extract — Gastroenterology · Recommended · 2020 Panitumumab — Oncology · Recommended · 2015 Paracetamol — Pain · Recommended · 2020 Paritaprevir With Ritonavir And Ombitasvir — Hepatology · Recommended · 2016 Paritaprevir / Ritonavir / Ombitasvir / Dasabuvir — Hepatology · Recommended · 2015 Pasireotide — Endocrinology · Recommended · 2015 Patiromer — Endocrinology · Recommended · 2023 Patisiran — Rare disease · Recommended · 2023 Pazopanib — Oncology · Recommended · 2013 Bosentan Monohydrate — Cardiovascular · Recommended · 2008 Clopidogrel Hydrogen Sulfate — Cardiovascular · Recommended · 2008 Desvenlafaxine Succinate — Mental health · Recommended · 2008 Duloxetine Hydrochloride — Mental health · Recommended · 2008 Escitalopram Oxalate — Mental health · Recommended · 2008 Fludarabine Phosphate — Haematology · Recommended · 2008 Ibandronic Acid — Oncology · Recommended · 2008 Imatinib Mesylate — Haematology · Recommended · 2008 Lanthanum Carbonate Hydrate — Endocrinology · Deferred · 2008 Lercanidipine With Enalapril — Cardiovascular · Recommended · 2008 Levetiracetam — Neurology · Recommended · 2008 Maraviroc — Immunology · Deferred · 2012 Memantine Hydrochloride — Neurology · Recommended · 2008 Methyl 5-Aminolevulinate Hydrochloride — Dermatology · Not recommended · 2008 Miglustat — Rare disease · Not recommended · 2011 Modafinil — Neurology · Not recommended · 2008 Nilotinib — Haematology · Recommended · 2011 Oseltamivir — Infectious disease · Not recommended · 2008 Paricalcitol — Endocrinology · Not recommended · 2011 Pegfilgrastim — Oncology · Recommended · 2020 Poly-L-Lactic Acid — Other · Recommended · 2009 Posaconazole — Infectious disease · Recommended · 2015 Pramipexole Hydrochloride — Neurology · Recommended · 2009 Raltegravir — Infectious disease · Deferred · 2017 Rotigotine — Neurology · Not recommended · 2008 Sibutramine Hydrochloride — Endocrinology · Not recommended · 2008 Sitagliptin Phosphate — Endocrinology · Recommended · 2008 Somatropin — Endocrinology · Recommended · 2023 Sorafenib Tosylate — Oncology · Not recommended · 2008 Sunitinib Malate — Oncology · Deferred · 2012 Tacrolimus — Dermatology · Recommended · 2025 Tamsulosin Hydrochloride — Urology · Recommended · 2010 Telbivudine — Hepatology · Recommended · 2008 Tenofovir Disoproxil Fumarate — Gastroenterology · Recommended · 2009 Teriparatide — Endocrinology · Recommended · 2025 Trastuzumab — Oncology · Recommended · 2021 Ziprasidone Hydrochloride — Mental health · Recommended · 2008 Zoledronic Acid — Oncology · Recommended · 2023 Zoster Virus Vaccine Live (Oka/Merk) — Vaccines · Recommended · 2008 Pegcetacoplan — Ophthalmology · Recommended · 2025 Peginterferon Beta-1a — Neurology · Recommended · 2014 Peginterferon Alfa-2a — Infectious disease · Recommended · 2017 Pegunigalsidase Alfa — Rare disease · Recommended · 2025 Pegvaliase — Metabolic · Recommended · 2022 Pegvisomant — Endocrinology · Recommended · 2019 Pemetrexed — Oncology · Recommended · 2023 Perampanel — Neurology · Recommended · 2017 Perfluorohexyloctane — Ophthalmology · Recommended · 2018 Pertussis Vaccine-Acellular, Combined With Diphtheria And Tetanus Toxoids (Dtap) — Vaccines · Recommended · 2015 Pertuzumab — Oncology · Recommended · 2025 Trastuzumab; Pertuzumab; Trastuzumab Emtansine — Oncology · Recommended · 2014 Pioglitazone — Endocrinology · Recommended · 2025 Pirfenidone — Respiratory · Recommended · 2018 Amino Acid Formula With Fat, Carbohydrate, Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without Phenylalanine And Supplemented With Docosahexaenoic Acid — Metabolic · Recommended · 2016 Amino Acid Formula With Carbohydrate, Vitamins, Minerals And Trace Elements Without Phenylalanine — Metabolic · Recommended · 2016 Plerixafor — Haematology · Recommended · 2013 Plitidepsin — Haematology · Not recommended · 2020 Pneumococcal Polysaccharide Conjugate 13-Valent — Vaccines · Recommended · 2018 Pneumococcal Conjugate Vaccine, 13-Valent — Vaccines · Recommended · 2016 Pneumococcal Conjugate Vaccine, 15-Valent — Vaccines · Recommended · 2023 21-Valent Pneumococcal Conjugate Vaccine — Vaccines · Recommended · 2025 Pneumococcal Polysaccharide Conjugate Vaccine, 13-Valent — Vaccines · Not recommended · 2018 Polatuzumab Vedotin — Haematology · Not recommended · 2025 Polyethylene Glycol 400 With Propylene Glycol — Ophthalmology · Recommended · 2025 Pomalidomide — Oncology · Recommended · 2023 Ponatinib — Haematology · Recommended · 2018 Pralatrexate — Oncology · Recommended · 2017 Prasugrel — Cardiovascular · Recommended · 2024 Prednisolone With Phenylephrine — Ophthalmology · Recommended · 2019 Pregabalin — Pain · Deferred · 2021 Primidone — Neurology · Recommended · 2019 Progesterone — Women's health · Recommended · 2024 Propranolol — Other · Not recommended · 2017 Propylene Glycol — Ophthalmology · Recommended · 2024 Protein Formula With Vitamins And Minerals, Low In Potassium, Phosphorus, Calcium, Chloride And Vitamin A — Metabolic · Recommended · 2020 Protein Formula With Carbohydrate, Fat, Vitamins, Minerals And Transforming Growth Factor Beta-2 — Gastroenterology · Not recommended · 2020 Protein Formula With Carbohydrate, Fat, Fibre, Vitamins And Minerals — Metabolic · Not recommended · 2015 Protein Hydrolysate Formula With Medium Chain Triglycerides — Metabolic · Recommended · 2018 Quadrivalent Influenza Vaccine (Split Virion, Inactivated) — Vaccines · Recommended · 2019 Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated, Cell-Based) — Vaccines · Recommended · 2022 Rabeprazole — Gastroenterology · Recommended · 2022 Radium-223 Dichloride — Oncology · Recommended · 2017 Ramucirumab — Oncology · Not recommended · 2019 Ranibizumab — Ophthalmology · Recommended · 2025 Ranolazine — Cardiovascular · Recommended · 2018 Ravulizumab — Neurology · Recommended · 2025 Raxtozinameran — Vaccines · Deferred · 2025 Regorafenib — Oncology · Recommended · 2021 Relatlimab And Nivolumab — Oncology · Recommended · 2023 Relatlimab With Nivolumab — Oncology · Recommended · 2022 Relugolix With Estradiol And Norethisterone Acetate — Women's health · Recommended · 2024 Repotrectinib — Oncology · Recommended · 2025 Recombinant Syncytial Pre-Fusion F Protein Vaccine (Rsvpref) — Vaccines · Not recommended · 2024 Mrna-1345 — Vaccines · Not recommended · 2025 Retifanlimab — Oncology · Recommended · 2025 Ribavirin — Hepatology · Recommended · 2016 Ribociclib — Oncology · Recommended · 2025 Rifampicin — Infectious disease · Recommended · 2020 Rifaximin — Hepatology · Not recommended · 2019 Riluzole — Neurology · Recommended · 2018 Rimegepant — Neurology · Recommended · 2024 Riociguat — Cardiovascular · Deferred · 2016 Ripretinib — Oncology · Recommended · 2021 Risankizumab — Dermatology · Recommended · 2023 Risdiplam — Rare disease · Recommended · 2025 Risedronate Sodium — Endocrinology · Deferred · 2023 Risperidone — Mental health · Recommended · 2024 Rituximab — Haematology · Recommended · 2021 Rivaroxaban — Cardiovascular · Not recommended · 2024 Rivastigmine — Neurology · Recommended · 2015 Romidepsin — Haematology · Deferred · 2017 Romiplostim And Eltrombopag — Haematology · Recommended · 2022 Romosozumab — Endocrinology · Recommended · 2024 Rozanolixizumab — Neurology · Recommended · 2025 Rsv Pre-Fusion F Protein Vaccine (Rsvpref) — Vaccines · Recommended · 2024 Respiratory Syncytial Virus Vaccine, Recombinant Pre-Fusion F Protein 3 Older Adult (Rsvpref3 Oa) — Vaccines · Not recommended · 2024 Ruxolitinib — Haematology · Recommended · 2025 Sacituzumab Govitecan — Oncology · Not recommended · 2025 Sacubitril With Valsartan — Cardiovascular · Recommended · 2024 Sacubitril/Valsartan — Cardiovascular · Recommended · 2020 Safinamide — Neurology · Recommended · 2018 Salbutamol — Respiratory · Recommended · 2020 Sapropterin — Metabolic · Not recommended · 2022 Sarilumab — Rheumatology · Not recommended · 2018 Saxagliptin And Metformin Extended Release — Endocrinology · Recommended · 2015 Saxagliptin With Metformin — Endocrinology · Deferred · 2013 Saxagliptin — Endocrinology · Recommended · 2015 Sebelipase Alfa — Metabolic · Recommended · 2022 Secukinumab — Dermatology · Recommended · 2023 Seladelpar — Hepatology · Recommended · 2025 Selexipag — Cardiovascular · Recommended · 2020 Selinexor — Oncology · Recommended · 2022 Selpercatinib — Oncology · Recommended · 2024 Selumetinib — Rare disease · Recommended · 2024 Semaglutide — Cardiovascular · Not recommended · 2025 Sevelamer Carbonate — Endocrinology · Recommended · 2019 Sevelamer — Endocrinology · Recommended · 2017 Siltuximab — Rare disease · Recommended · 2021 Simeprevir — Hepatology · Recommended · 2016 Siponimod — Neurology · Recommended · 2024 Sitagliptin — Endocrinology · Not recommended · 2015 Sodium Phenylbutyrate — Metabolic · Recommended · 2019 Sodium Zirconium Cyclosilicate — Endocrinology · Recommended · 2024 Sofosbuvir With Velpatasvir — Infectious disease · Not recommended · 2017 Sofosbuvir — Hepatology · Recommended · 2015 Sofosbuvir With Velpatasvir And Voxilaprevir — Hepatology · Recommended · 2018 Somapacitan — Endocrinology · Recommended · 2023 Somatrogon — Endocrinology · Recommended · 2022 Sonidegib — Dermatology · Not recommended · 2023 Sorafenib — Oncology · Not recommended · 2015 Sotatercept — Respiratory · Recommended · 2025 Sotorasib — Oncology · Recommended · 2022 Stiripentol — Neurology · Recommended · 2020 Strontium Ranelate — Endocrinology · Not recommended · 2015 Sucroferric Oxyhydroxide — Endocrinology · Not recommended · 2015 Sunitinib — Oncology · Recommended · 2013 Tadalafil — Cardiovascular · Recommended · 2024 Tafamidis — Cardiovascular · Recommended · 2023 Tafasitamab — Haematology · Recommended · 2025 Tagraxofusp — Haematology · Other · 2023 Talazoparib — Oncology · Recommended · 2024 Taliglucerase Alfa — Metabolic · Not recommended · 2014 Talimogene Laherparepvec — Oncology · Not recommended · 2016 Tamoxifen — Oncology · Recommended · 2016 Tapentadol — Pain · Recommended · 2013 Tenofovir Disoproxil Fumarate With Emtricitabine / Tenofovir Disoproxil Maleate With Emtricitabine / Tenofovir Disoproxil Phosphate With Emtricitabine — Infectious disease · Recommended · 2020 Tebentafusp — Oncology · Recommended · 2023 Teduglutide — Gastroenterology · Recommended · 2021 Tenofovir Alafenamide, Emtricitabine, And Rilpivirine — Infectious disease · Recommended · 2016 Bictegravir + Emtricitabine + Tenofovir Alafenamide — Infectious disease · Deferred · 2018 Tenofovir Alafenamide/Emtricitabine — Infectious disease · Recommended · 2016 Emtricitabine + Tenofovir Alafenamide — Infectious disease · Recommended · 2016 Tenofovir Alafenamide — Hepatology · Recommended · 2017 Emtricitabine/Tenofovir Disoproxil Fumarate — Infectious disease · Not recommended · 2016 Tenofovir Disoproxil Maleate With Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir With Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir Disoproxil Fumarate / Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir Disoproxil Fumarate With Emtricitabine And Efavirenz; Tenofovir Disoproxil Fumarate With Emtricitabine And Rilpivirine; Tenofovir Disoproxil Fumarate With Emtricitabine, Elvitegravir And Cobicistat — Infectious disease · Deferred · 2019 Tepotinib — Oncology · Recommended · 2021 Teprotumumab — Ophthalmology · Recommended · 2025 Terbutaline — Respiratory · Recommended · 2020 Teriflunomide — Neurology · Not recommended · 2016 Testosterone — Women's health · Not recommended · 2025 Tetracosactide — Neurology · Deferred · 2021 Tetracosactrin — Neurology · Recommended · 2017 Tezacaftor With Ivacaftor — Rare disease · Recommended · 2019 Tezepelumab — Respiratory · Recommended · 2025 Oxycodone, Tramadol, Codeine, Hydromorphone, Morphine, Tapentadol, Buprenorphine, Fentanyl — Pain · Recommended · 2019 Thiazolidinediones, Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Co-Transporter 2 Inhibitors — Diabetes · Deferred · 2014 Thyroxine Sodium — Endocrinology · Not recommended · 2016 Ticagrelor — Cardiovascular · Not recommended · 2023 Tildrakizumab — Dermatology · Recommended · 2023 Tiotropium — Respiratory · Recommended · 2024 Tiotropium Bromide — Respiratory · Recommended · 2015 Tiotropium Bromide Plus Olodaterol Hydrochloride — Respiratory · Recommended · 2015 Tiotropium With Olodaterol — Respiratory · Recommended · 2024 Tiotropium Bromide With Olodaterol Hydrochloride — Respiratory · Recommended · 2017 Tirzepatide — Endocrinology · Recommended · 2025 Tislelizumab — Oncology · Recommended · 2024 Tixagevimab And Cilgavimab — Infectious disease · Recommended · 2022 Tobramycin — Infectious disease · Recommended · 2013 Tocilizumab — Rheumatology · Not recommended · 2025 Tofacitinib — Rheumatology · Recommended · 2024 Tofersen — Neurology · Recommended · 2025 Tolvaptan — Rare disease · Recommended · 2019 Topotecan — Oncology · Recommended · 2020 Toripalimab — Oncology · Recommended · 2025 Trabectedin — Oncology · Recommended · 2021 Tramadol Hydrochloride With Paracetamol — Pain · Not recommended · 2018 Trametinib — Oncology · Recommended · 2016 Trastuzumab Deruxtecan — Oncology · Recommended · 2025 Trastuzumab Emtansine — Oncology · Recommended · 2019 Trientine Tetrahydrochloride — Rare disease · Recommended · 2022 Trientine Dihydrochloride — Metabolic · Recommended · 2023 Trifluridine With Tipiracil — Oncology · Recommended · 2019 Triglycerides Medium Chain Formula — Metabolic · Recommended · 2020 Triglycerides Long Chain With Glucose Polymer — Metabolic · Recommended · 2014 Triglycerides, Long Chain With Glucose Polymer — Metabolic · Recommended · 2024 Triglycerides Medium Chain And Long Chain With Glucose Polymer — Metabolic · Recommended · 2020 Medium Chain Triglycerides; Protein Formula With Carbohydrate, Fat, Vitamins And Minerals — Metabolic · Recommended · 2019 Medium Chain Triglycerides Formula — Metabolic · Recommended · 2016 Triglycerides, Medium Chain — Metabolic · Recommended · 2022 Triptorelin — Endocrinology · Recommended · 2021 Triptorelin Acetate — Women's health · Recommended · 2016 Trivalent Influenza Vaccine — Vaccines · Recommended · 2014 Tucatinib — Oncology · Recommended · 2025 Tyrosine With Carbohydrate — Metabolic · Recommended · 2019 Ublituximab — Neurology · Recommended · 2025 Ulipristal Acetate — Women's health · Not recommended · 2017 Umeclidinium Bromide — Respiratory · Recommended · 2014 Umeclidinium Bromide And Vilanterol Trifenatate — Respiratory · Not recommended · 2014 Umeclidinium + Vilanterol — Respiratory · Not recommended · 2014 Upadacitinib — Rheumatology · Recommended · 2023 Ursodeoxycholic Acid — Hepatology · Recommended · 2023 Ustekinumab — Dermatology · Recommended · 2025 Vanzacaftor/Tezacaftor/Deutivacaftor — Rare disease · Recommended · 2025 Varenicline — Mental health · Recommended · 2017 Varicella Zoster Virus Recombinant Vaccine — Vaccines · Recommended · 2023 Recombinant Varicella Zoster Virus Glycoprotein E Antigen (As01b Adjuvanted) Vaccine — Vaccines · Recommended · 2018 Vedolizumab — Gastroenterology · Deferred · 2025 Velmanase Alfa — Metabolic · Recommended · 2025 Vemurafenib — Oncology · Deferred · 2013 Venetoclax — Haematology · Recommended · 2021 Vericiguat — Cardiovascular · Recommended · 2022 Verteporfin — Ophthalmology · Recommended · 2005 Vildagliptin/Metformin — Endocrinology · Not recommended · 2013 Vildagliptin — Endocrinology · Recommended · 2017 Vinflunine — Oncology · Not recommended · 2017 Vismodegib — Oncology · Recommended · 2017 Vitamins, Minerals And Trace Elements With Carbohydrate — Metabolic · Recommended · 2020 Vitamins, Minerals And Trace Elements Formula — Metabolic · Recommended · 2017 Vorasidenib — Oncology · Recommended · 2025 Voriconazole — Infectious disease · Recommended · 2014 Vorinostat — Oncology · Recommended · 2017 Vortioxetine — Mental health · Not recommended · 2014 Vosoritide — Rare disease · Recommended · 2022 Vutrisiran — Rare disease · Recommended · 2024 Warfarin — Cardiovascular · Not recommended · 2016 Whey Protein Formula With Medium Chain Triglycerides, Carbohydrate, Vitamins And Minerals — Metabolic · Deferred · 2016 Whey Protein Formula Supplemented With Amino Acids, Vitamins And Minerals, And Low In Protein, Phosphate, Potassium And Lactose — Metabolic · Recommended · 2020 Zanubrutinib — Haematology · Recommended · 2025 Zilucoplan — Neurology · Not recommended · 2025 Zolbetuximab — Oncology · Recommended · 2025 Zoster Virus Vaccine Live — Vaccines · Deferred · 2014 Adefovir Dipivoxil — Hepatology · Recommended · 2007 Anastrozole, Everolimus, Exemestane, Goserelin, Letrozole — Oncology · Recommended · 2014 Cinacalcet Hydrochloride — Endocrinology · Not recommended · 2009 Darunavir — HIV/AIDS · Not recommended · 2010 Dutasteride — Urology · Not recommended · 2009 Galsulfase — Rare disease · Not recommended · 2007 Human Papillomavirus (Types 16 And 18) Recombinant, As04 Adjuvanted Vaccine — Immunology · Recommended · 2007 Idursulfase — Rare disease · Not recommended · 2007 Influenza Vaccine — Other · Not recommended · 2007 Ivabradine Hydrochloride — Cardiovascular · Not recommended · 2009 Lapatinib Ditosylate — Oncology · Not recommended · 2007 Lapatinib Ditosylate Monohydrate — Oncology · Not recommended · 2007 Macrogol 3350 — Gastroenterology · Recommended · 2007 Pioglitazone Hydrochloride — Diabetes · Recommended · 2007 Quetiapine Fumarate — Mental health · Not recommended · 2009 Rosiglitazone Maleate — Diabetes · Not recommended · 2007 Sevelamer Hydrochloride — Renal · Recommended · 2007 Sitaxentan Sodium — Cardiovascular · Recommended · 2007 Solifenacin — Urology · Recommended · 2010 Tazarotene — Dermatology · Not recommended · 2007 Terbinafine — Other · Recommended · 2007 Tsp (Tamarindus Indica Seed Polysaccharide) — Ophthalmology · Recommended · 2007 Varenicline Tartrate — Other · Recommended · 2009 Zonisamide — Neurology · Recommended · 2007 Pcv15 — Infectious disease · Recommended · 2021 Abiraterone — Oncology · Recommended · 2012 Adapalene With Benzoyl Peroxide — Dermatology · Recommended · 2010 Agalsidase Alfa — Rare disease · Not recommended · 2009 Agomelatine — Mental health · Not recommended · 2012 Alefacept — Dermatology · Not recommended · 2005 Alendronate Sodium With Colecalciferol — Endocrinology · Recommended · 2006 Alendronate Sodium, Tablet — Endocrinology · Recommended · 2006 Aliskiren — Cardiovascular · Not recommended · 2010 Ambrisentan — Respiratory · Recommended · 2009 Amino Acid Formula With Fat, Carbohydrate Without Methionine — Metabolic · Recommended · 2019 Amlodipine Besylate With Atorvastatin Calcium — Cardiovascular · Recommended · 2006 Amlodipine (As Besylate) With Valsartan And Hydrochlorothiazide — Cardiovascular · Recommended · 2010 Anecortave Acetate — Ophthalmology · Recommended · 2006 Asenapine — Mental health · Recommended · 2011 Atomoxetine Hydrochloride — Neurology · Recommended · 2008 Aztreonam — Respiratory · Recommended · 2012 Bimatoprost With Timolol Maleate — Ophthalmology · Recommended · 2009 Boceprevir — Hepatology · Recommended · 2012 Boceprevir And Ribavirin And Peginterferon Alfa-2b — Hepatology · Not recommended · 2012 Buprenorphine Hydrochloride With Naloxone Hydrochloride — Pain · Recommended · 2005 Capecitabine — Oncology · Recommended · 2011 Capivasertib — Oncology · Recommended · 2024 Carmustine — Oncology · Not recommended · 2008 Carmustine, Implant — Oncology · Recommended · 2005 Cilostazol — Other · Not recommended · 2010 Ciprofloxacin, Ear Drops — Other · Recommended · 2006 Clindamycin Phosphate With Benzoyl Peroxide, Gel — Dermatology · Not recommended · 2009 Clostridium Botulinum Type A Toxin Haemagglutinin Complex — Neurology · Recommended · 2011 Colistimethate Sodium — Respiratory · Not recommended · 2011 Calcipotriol With Betamethasone Dipropionate, Ointment — Dermatology · Recommended · 2009 Dabigatran Etexilate Mesilate — Other · Deferred · 2009 Dalteparin Sodium — Other · Recommended · 2010 Dorzolamide Hydrochloride With Timolol Maleate, Eye Drops — Ophthalmology · Recommended · 2012 Doxorubicin Hydrochloride, Pegylated Liposomal — Haematology · Not recommended · 2008 Dronedarone Hydrochloride — Cardiovascular · Not recommended · 2010 Dutasteride With Tamsulosin Hydrochloride — Urology · Recommended · 2010 Eletriptan Hydrobromide — Pain · Recommended · 2010 Eltrombopag Olamine — Haematology · Not recommended · 2010 Entecavir — Gastroenterology · Recommended · 2006 Epoprostenol Sodium — Respiratory · Recommended · 2011 Esomeprazole Magnesium Trihydrate — Gastroenterology · Recommended · 2005 Etoricoxib — Pain · Not recommended · 2008 Etravirine — Immunology · Recommended · 2009 Exemestane — Oncology · Recommended · 2006 Ezetimibe — Cardiovascular · Recommended · 2010 Famciclovir — Immunology · Recommended · 2006 Fentanyl, Transdermal Patch — Pain · Recommended · 2006 Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine — Other · Recommended · 2011 Glucosamine Hydrochloride — Pain · Not recommended · 2006 Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine — Other · Recommended · 2011 Hydroxyethyl Starch 130/0.4 — Other · Recommended · 2009 Hylan G-F 20 — Musculo-skeletal · Not recommended · 2006 Imiquimod, Cream — Dermatology · Not recommended · 2009 Imiquimod — Dermatology · Not recommended · 2008 Indacaterol Maleate — Respiratory · Not recommended · 2010 Indacaterol — Respiratory · Recommended · 2011 Influenza Vaccine, Injection — Other · Recommended · 2009 Insulin Glulisine — Endocrinology · Recommended · 2007 Interferon Beta-1b — Neurology · Not recommended · 2007 Ferrous Fumurate With Folic Acid — Other · Recommended · 2006 Lanthanum Carbonate — Renal disease · Not recommended · 2007 Leflunomide — Rheumatology · Recommended · 2007 Letrozole — Oncology · Recommended · 2007 Levodopa With Carbidopa Monohydrate, Intestinal Gel — Neurology · Not recommended · 2009 Levonorgestrel, Intrauterine Drug Delivery System — Women's health · Recommended · 2007 Losartan — Cardiovascular · Recommended · 2010 Lumiracoxib — Musculo-skeletal · Recommended · 2005 Methoxyflurane — Pain · Recommended · 2008 Methyl Aminolevulinate — Oncology · Not recommended · 2005 Methylnaltrexone Bromide — Pain · Recommended · 2009 Milnacipran — Pain · Not recommended · 2012 Montelukast Sodium — Respiratory · Recommended · 2009 Moxonidine — Cardiovascular · Recommended · 2006 Mycophenolic Acid — Rheumatology · Recommended · 2012 Mycophenolate Sodium — Rheumatology · Recommended · 2011 Nebivolol Hydrochloride — Cardiovascular · Recommended · 2009 Nicotine, Transdermal Patch — Pain · Recommended · 2010 Nicotinic Acid — Cardiovascular · Not recommended · 2007 Olanzapine Pamoate Monohydrate — Psychiatry · Recommended · 2009 Olmesartan Medoxomil With Hydrochlorothiazide — Cardiovascular · Recommended · 2007 Olmesartan Medoxomil — Cardiovascular · Recommended · 2005 Olmesartan Medoxomil With Amlodipine — Cardiovascular · Recommended · 2010 Omega-3-Acid Ethyl Esters — Cardiovascular · Not recommended · 2010 Oxycodone Hydrochloride And Naloxone Hydrochloride Dihydrate — Pain · Not recommended · 2010 Oxycodone Hydrochloride With Naloxone Hydrochloride Dihydrate — Pain · Recommended · 2010 Paclitaxel — Oncology · Recommended · 2006 Palonosetron Hydrochloride — Oncology · Recommended · 2010 Peginterferon Alfa-2b — Gastroenterology · Recommended · 2005 Pemetrexed Disodium — Oncology · Not recommended · 2005 Perindopril Arginine With Amlodipine Besylate — Cardiovascular · Recommended · 2010 Pertussis Vaccine Acellular With Diphtheria And Tetanus Toxoids, Adsorbed — Immunology · Recommended · 2006 Adacel — Immunology · Not recommended · 2011 Pimecrolimus — Dermatology · Recommended · 2006 Pneumococcal Polysaccharide Conjugate Vaccine — Immunology · Recommended · 2009 Pramipexole — Neurology · Not recommended · 2006 Prucalopride — Gastroenterology · Not recommended · 2012 Ramipril With Felodipine — Cardiovascular · Recommended · 2007 Rasagiline — Neurology · Recommended · 2012 Peginterferon Alfa-2a, Ribavirin — Hepatology · Recommended · 2010 Ribavirin And Peginterferon Alfa-2b — Hepatology · Recommended · 2011 Romiplostim — Haematology · Recommended · 2010 Ropinirole — Neurology · Not recommended · 2006 Rosiglitazone Maleate With Metformin Hydrochloride — Diabetes · Recommended · 2006 Rosuvastatin Calcium — Cardiovascular · Recommended · 2006 Human Rotavirus Vaccine — Immunology · Recommended · 2006 Rotavirus Vaccine — Immunology · Not recommended · 2006 Rotavirus Vaccine, Live, Oral Liquid, Pentavalent — Immunology · Recommended · 2006 Salbutamol Sulfate — Respiratory · Not recommended · 2010 Sapropterin Dihydrochloride — Metabolic · Recommended · 2011 Sertindole — Mental health · Not recommended · 2011 Sildenafil Citrate — Respiratory · Recommended · 2006 Sitagliptin With Simvastatin — Endocrinology · Recommended · 2012 Tafluprost — Ophthalmology · Recommended · 2012 Telaprevir — Hepatology · Recommended · 2012 Telmisartan With Amlodipine — Cardiovascular · Recommended · 2011 Temsirolimus — Oncology · Not recommended · 2008 Tenofovir Disoproxil Fumarate With Emtricitabine — HIV/AIDS · Recommended · 2005 Tenofovir Disoproxil Fumarate With Emtricitabine And Rilpivirine Hydrochloride — Immunology · Recommended · 2011 Testosterone Undecanoate — Endocrinology · Recommended · 2005 Thalidomide — Oncology · Recommended · 2009 Thyrotropin Alfa — Endocrinology · Recommended · 2007 Tipranavir — Infectious disease · Recommended · 2007 Tobramycin, Solution For Inhalation — Respiratory · Recommended · 2011 Topiramate — Neurology · Recommended · 2007 Trandolapril With Verapamil — Cardiovascular · Not recommended · 2005 Trandolapril With Verapamil Hydrochloride-Sr — Cardiovascular · Recommended · 2006 Travoprost With Timolol Maleate, Eye Drops — Ophthalmology · Recommended · 2007 Travoprost With Timolol Maleate — Ophthalmology · Not recommended · 2005 Treprostinil Sodium — Cardiovascular · Recommended · 2005 Valsartan With Hydrochlorothiazide — Cardiovascular · Recommended · 2008 Amlodipine Besylate With Valsartan — Cardiovascular · Recommended · 2008 Velaglucerase Alfa — Rare disease · Not recommended · 2012 Vinorelbine Tartrate — Oncology · Recommended · 2006 Vinorelbine — Oncology · Not recommended · 2012 Whey Protein Formula Supplemented With Amino Acids, Long Chain Polyunsaturated Fatty Acids, Vitamins And Minerals, Low In Protein, Phosphate, Potassium And Lactose — Other · Recommended · 2020

UMAP over decision-profile embeddings · one point per drug · 1,008 drugs